DexCom had 86 patents in internet of things during Q2 2024. DexCom Inc filed patents in Q2 2024 for systems and methods to generate graphical displays of analyte data, sensor interposers with castellated through-vias for electrical isolation, contemporaneous insight notifications based on analyte data, calibration of analyte sensors within biological systems, and transcutaneous measurement of glucose in hosts. GlobalData’s report on DexCom gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
DexCom had no grants in internet of things as a theme in Q2 2024.
Recent Patents
Application: Systems and methods for health data visualization and user support tools for continuous glucose monitoring (Patent ID: US20240197264A1)
The patent filed by DexCom Inc. discloses systems and methods for generating graphical displays of analyte data and health information. These graphical displays are based on a self-referential dataset that can be modified to indicate features in the analyte data of a host. The patent includes claims related to an analyte monitoring system comprising a continuous analyte sensor, sensor electronics module, and display devices like a smartwatch and smartphone for generating visual representations of the analyte data.
The system allows for the direct transmission of analyte data from the sensor electronics module to the display devices, where each device can generate graphical user interfaces to display visual representations of the data. The patent also covers variations in the content and format of the data packages transmitted to different display devices, as well as the sequential or simultaneous generation of alarms based on the analyte data. Additionally, the method claims involve the measurement of analyte concentration, generation of analyte data, and wireless transmission to multiple display devices, each capable of generating visual representations of the data with or without additional processing. The patent aims to enhance the monitoring and display of analyte data for improved health management.
To know more about GlobalData’s detailed insights on DexCom, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
